The FDA will hold a public hearing June 12 to gather feedback on its Commissioner’s National Priority Voucher pilot program.
The hearing will be held at the agency’s White Oak campus in Silver Spring, Md., with options to attend virtually, according to a March 20 news release. Stakeholders have until May 1 to request to speak. Written comments will be accepted through June 27.
The voucher program was launched in June 2025 to accelerate FDA review of drugs and biologics tied to national health priorities. To date, 18 products have been awarded vouchers and four have received approval, including two oncology therapies approved 44 and 55 days after filing.
The pilot offers a one- to two-month review timeline, enhanced presubmission engagement and a multidisciplinary review process led by the CNPV Review Council.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
